e-learning
resources
Madrid 2019
Saturday, 28.09.2019
PG14 Perioperative management of fragile patients undergoing major thoracic surgery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Physio-pathologic assessment to stratify risk
A. Aliverti (Milan, Italy)
Source:
International Congress 2019 – PG14 Perioperative management of fragile patients undergoing major thoracic surgery
Session:
PG14 Perioperative management of fragile patients undergoing major thoracic surgery
Session type:
Postgraduate Course
Number:
159
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Aliverti (Milan, Italy). Physio-pathologic assessment to stratify risk. International Congress 2019 – PG14 Perioperative management of fragile patients undergoing major thoracic surgery
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
N3 hilar sampling decision in the staging of mediastinal lung cancer
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Related content which might interest you:
Blood biomarker algorithms to guide COPD assessment and risk stratification
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
How to stratify the risk of failure of noninvasive respiratory assistance
Source: Virtual Congress 2020 – Noninvasive respiratory assistance for acute respiratory failure outside the intensive care unit: a bargain or a burden?
Year: 2020
Spirometry for the risk stratification of cardiovascular disease among the elderly
Source: Eur Respir J 2007; 30: Suppl. 51, 311s
Year: 2007
Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014
Which type of pre-operative risk assessment for which patients
Source: Annual Congress 2012 - Current challenges in multimodality lung cancer treatment
Year: 2012
Harvesting biomarkers for early risk assessment
Source: Annual Congress 2008 - New age lung carcinogenesis: clinical impact
Year: 2008
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Individual risk and prognostic factors for asthma according to the natural history of the disease
Source: Annual Congress 2003 - Risk factors for asthma
Year: 2003
Occupational risk factors may be of importance to define populations suitable to screening of lung cancer
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011
Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Prevalence of COPD in the general population according to cardiovascular risk factors
Source: Eur Respir J 2007; 30: Suppl. 51, 778s
Year: 2007
Are biomarkers helpful in sepsis for risk assessment or clinical trials?
Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients
Year: 2011
Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020
Year: 2020
An innovative risk score for prediction of asthma related adverse outcome
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009
Development and validation of a screening algorithm for perioperative risk of complications in patients suspected with OSA.
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018
Incidence and specific risk factors of falling in pulmonary rehabilitation
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept